TSHA - long - catalyst play

16 de fev.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. It is advancing a deep and sustainable product portfolio of 18 gene therapy product candidates, with exclusive options to acquire four additional development programs. Its product candidates include TSHA-101, TSHA-118, TSHA-102, TSHA-103, and TSHA-104

This is not a financial advice!

Upcoming catalyst on 31st. of March

We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.

13% short float

Rel. Vol. at 3.13

Block buys and Passive Stakes

Keep an eye on 2.0, 2.50, 3.0, 3.9 and 5.0 level, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.

SL under 1.10

TP approx. 5.0

Most info on the chart.

Trade carefully!

20 de fev.

Nota

let's go

29 de fev.

Nota

Wednesday February 28, 2024
11:37:21AM

TSHA
Block Trade: TSHA 7.6M @ $2.55 at the bid

1 de mar.

Nota

crazzzzyyy

30 de mar.

Nota

Thursday March 28, 2024
05:32:52PM
TSHA
Block Trade: TSHA 1.2M @ $2.87 at the ask
Signals
Monday March 25, 2024
05:29:52PM
TSHA
Block Trade: TSHA 654,800 @ $3.06 at the bid

19 de mai.

Trade fechado: objetivo atingido

1 de jun.

Nota